Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease (Q53317540)

13 May 2018

title

Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

27 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21414686

27 November 2024

William L Klein

1 reference

13 May 2018

Augusto Claudio Cuello

object named as

A. Claudio Cuello

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21414686

27 November 2024

author name string

Maria Teresa Ferretti

1 reference

13 May 2018

Adriana Ducatenzeiler

1 reference

13 May 2018

Martin A. Bruno

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21414686

27 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21414686

27 November 2024

publication date

16 March 2011

1 reference

13 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0197458011000091?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

https://api.elsevier.com/content/article/PII:S0197458011000091?httpAccept=text/plain

27 November 2024

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

27 November 2024

published in

Neurobiology of Aging

1 reference

13 May 2018

volume

1 reference

13 May 2018

issue

1 reference

13 May 2018

page(s)

1329-1342

1 reference

13 May 2018

Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice

cites work

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Inflammation and Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Increased matrix metalloproteinase 9 activity in mild cognitive impairment

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

In-vivo measurement of activated microglia in dementia

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Phagocytosis stimulates alternative glycosylation of macrosialin (mouse CD68), a macrophage-specific endosomal protein

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

From inflammation to sickness and depression: when the immune system subjugates the brain

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Transgenic Mice as a Model of Pre-Clinical Alzheimers Disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Beta-amyloid stimulates murine postnatal and adult microglia cultures in a unique manner.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Long-term intracerebral inflammatory response after experimental focal brain injury in rat.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Are we prepared to deal with the Alzheimer's disease pandemic?

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

The impact of Aβ-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Monoclonal antibodies that target pathological assemblies of Abeta

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

The role of microglia in amyloid clearance from the AD brain

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Cognitive impairment and transmitter-specific pre- and postsynaptic changes in the rat cerebral cortex during ageing

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Macrophage polarization comes of age.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Anti-inflammatory drugs and Alzheimer disease.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

The role of microglia in antibody-mediated clearance of amyloid-beta from the brain

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Mild cognitive impairment represents early-stage Alzheimer disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Expression of macrophage colony-stimulating factor receptor is increased in the AbetaPP(V717F) transgenic mouse model of Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Oxidative damage is the earliest event in Alzheimer disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Microglial activation and amyloid deposition in mild cognitive impairment: a PET study

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Early diagnosis of Alzheimer's disease: is MCI too late?

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Mild cognitive impairment: clinical characterization and outcome

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Neuroinflammation-induced acceleration of amyloid deposition in the APPV717F transgenic mouse

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Deficient activation of microglia during optic nerve degeneration

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

The role of Galectin-3/MAC-2 in the activation of the innate-immune function of phagocytosis in microglia in injury and disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Developmental plasticity of CNS microglia

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Alzheimer's disease: genes, proteins, and therapy

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Development of a mouse antiperoxidase secreting hybridoma for use in the production of a mouse PAP complex for immunocytochemistry and as a parent cell line in the development of hybrid hybridomas

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Widespread peroxynitrite-mediated damage in Alzheimer's disease

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Risk of Alzheimer's disease and duration of NSAID use.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Post-training cyclooxygenase-2 (COX-2) inhibition impairs memory consolidation

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Inducible nitric oxide synthase gene expression in the brain during systemic inflammation

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Intracellular accumulation of insoluble, newly synthesized abetan-42 in amyloid precursor protein-transfected cells that have been treated with Abeta1-42.

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Temporal and topographic profiles of cyclooxygenase-2 expression during 24 h of focal brain ishemia in rats

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.NEUROBIOLAGING.2011.01.007

27 November 2024

Identifiers

1 reference

13 May 2018

1 reference

13 May 2018